Absorbed Organ Dose Coefficients and Absorbed Organ Doses (150 MBq of 68Ga-Pentixafor)
| Target organ | β (mGy/MBq) | Photon (mGy/MBq) | Total (mGy/MBq) | Absorbed dose (mGy) (150 MBq) |
| Adrenals | 7.10E–03 | 5.18E–03 | 1.23E–02 | 1.85 |
| Brain | 7.10E–03 | 2.93E–03 | 1.00E–02 | 1.50 |
| Breasts | 7.10E–03 | 2.78E–03 | 9.88E–03 | 1.48 |
| Gallbladder wall | 9.27E–03 | 5.30E–03 | 1.46E–02 | 2.19 |
| Lower large intestine wall | 7.10E–03 | 5.38E–03 | 1.25E–02 | 1.88 |
| Small intestine | 7.10E–03 | 5.18E–03 | 1.23E–02 | 1.85 |
| Stomach wall | 7.10E–03 | 4.84E–03 | 1.19E–02 | 1.79 |
| Upper large intestine wall | 7.10E–03 | 5.00E–03 | 1.21E–02 | 1.82 |
| Heart wall | 2.06E–02 | 5.88E–03 | 2.65E–02 | 3.98 |
| Kidneys | 2.84E–02 | 6.61E–03 | 3.50E–02 | 5.25 |
| Liver | 1.22E–02 | 5.30E–03 | 1.75E–02 | 2.68 |
| Lungs | 7.10E–03 | 3.91E–03 | 1.10E–02 | 1.65 |
| Muscle | 7.10E–03 | 3.78E–03 | 1.09E–02 | 1.64 |
| Ovaries | 7.10E–03 | 5.54E–03 | 1.26E–02 | 1.89 |
| Pancreas | 7.10E–03 | 5.74E–03 | 1.28E–02 | 1.92 |
| Red marrow | 9.72E–03 | 4.27E–03 | 1.40E–02 | 2.10 |
| Osteogenic cells | 1.40E–02 | 4.36E–03 | 1.84E–02 | 2.76 |
| Skin | 7.10E–03 | 2.43E–03 | 9.53E–03 | 1.43 |
| Spleen | 4.53E–02 | 8.50E–03 | 5.38E–02 | 8.07 |
| Testes | 7.10E–03 | 3.92E–03 | 1.10E–02 | 1.65 |
| Thymus | 7.10E–03 | 4.19E–03 | 1.13E–02 | 1.70 |
| Thyroid | 7.10E–03 | 3.74E–03 | 1.08E–02 | 1.62 |
| Urinary bladder wall | 6.91E–02 | 1.23E–02 | 8.14E–02 | 12.21 |
| Uterus | 7.10E–03 | 6.53E–03 | 1.36E–02 | 2.04 |
| Total body | 7.91E–03 | 3.80E–03 | 1.17E–02 | 1.76 |
| Effective dose coefficient (mSv/MBq) | 1.56E–02 | |||
| Effective dose coefficient (mSv/MBq)* | 1.58E–02 ± 0.06E–02 | |||
| Effective dose (mSv) | 2.34 |
↵* Mean value of patients 1–5 (P1–P5).